← Leaderboards
Muktar Hassan Aliyu
Vanderbilt University Medical Center
$9,351,975
Attributed
$22,406,447
Total exposure
11
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,406,447 · 11
By mechanism
D43$9,282,343 · 3
R01$8,450,536 · 3
U01$3,214,178 · 1
R21$654,352 · 2
R25$498,505 · 1
G11$306,533 · 1
Top collaborators
- Douglas C Heimburger21 shared
- William Wester18 shared
- Michael Rutledge Debaun7 shared
- Lori Chaffin Jordan6 shared
- Mahmoud Umar Sani6 shared
- Zubairu Iliyasu5 shared
- Nafiu Hussaini4 shared
- Baba Maiyaki Musa4 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- William Wester$4,962,334
- Deborah Le Cragun$2,003,974
- Baba Maiyaki Musa$734,023
- Michael Rutledge Debaun$40,846,229
- Scott Alan Smith$10,215,145
Others in their field
Top investigators on “Nigeria”
- William Albert Blattner · University Of Maryland Baltimore$216,422,779
- Patrick Dakum · Institute Of Human Virology$46,871,591
- Robert F Garry · Scripps Research Institute, The$26,056,895
- Margaret A Pericak-Vance · Doheny Eye Institute$20,572,172
- Bolanle Oyeledun · Centre For Integrated Health Programs$18,648,374
- Clement Adebayo Adebamowo · University Of Ibadan$16,856,483
Research focus
NigeriaFundingAfricaInstitutionUnited States National Institutes Of HealthTraining ProgramsFacultyMentorsGrantProgramsGlobal HealthSiteBaseTeaching HospitalsMemberClinical ResearchSkillsResourcesMonitorInnovationMeetingsResearch And DevelopmentResearch TrainingMentorship
Grant awards (57)
Vanderbilt-Nigeria Building Research Capacity in HIV and Non-communicable Diseases (NCDs) (V-BRCH) 2$301,882
D43 · FY2025 · TW
Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat)$297,793
D43 · FY2025 · TW
Vanderbilt-Nigeria Research Ethics Training Program (V-NET)$248,104
R25 · FY2025 · TW · contact PI
Etiology of Persistent Microalbuminuria in Nigeria$505,846
R01 · FY2024 · DK
Vanderbilt-Nigeria Building Research Capacity in HIV and Non-communicable Diseases (NCDs) (V-BRCH)$302,162
D43 · FY2024 · TW · contact PI
Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat)$297,848
D43 · FY2024 · TW
Vanderbilt-Nigeria Research Ethics Training Program (V-NET)$250,401
R25 · FY2024 · TW · contact PI
Etiology of Persistent Microalbuminuria in Nigeria$526,922
R01 · FY2023 · DK
Vanderbilt-Nigeria Building Research Capacity in HIV and Non-communicable Diseases (NCDs) (V-BRCH)$300,842
D43 · FY2023 · TW · contact PI
Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat)$297,669
D43 · FY2023 · TW
Vanderbilt-Nigeria Research Administration and Management Training Program (V-RAMP)$101,511
G11 · FY2023 · TW · contact PI
Optimal Management of HIV Infected Adults at Risk for Kidney Disease in Nigeria$584,447
U01 · FY2022 · DK
Etiology of Persistent Microalbuminuria in Nigeria$552,775
R01 · FY2022 · DK
Vanderbilt-Nigeria Building Research Capacity in HIV and Non-communicable Diseases (NCDs) (V-BRCH)$301,113
D43 · FY2022 · TW · contact PI
Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat)$299,500
D43 · FY2022 · TW
Vanderbilt-Nigeria Research Administration and Management Training Program (V-RAMP)$101,511
G11 · FY2022 · TW · contact PI
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$900,000
D43 · FY2021 · TW
Etiology of Persistent Microalbuminuria in Nigeria$616,525
R01 · FY2021 · DK
Vanderbilt-Nigeria Building Research Capacity in HIV and Non-communicable Diseases (NCDs) (V-BRCH)$300,842
D43 · FY2021 · TW · contact PI
Vanderbilt-Emory-Cornell-Duke Global Health Fellowship Consortium-Expanding Diversity for Global Equity (EDGE)$152,013
D43 · FY2021 · TW
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$125,596
D43 · FY2021 · TW
Vanderbilt-Nigeria Research Administration and Management Training Program (V-RAMP)$103,511
G11 · FY2021 · TW · contact PI
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$1,047,288
D43 · FY2020 · TW
Optimal Management of HIV Infected Adults at Risk for Kidney Disease in Nigeria$586,149
U01 · FY2020 · DK
Vanderbilt-Nigeria Building Research Capacity in HIV and Non-communicable Diseases (NCDs) (V-BRCH)$303,230
D43 · FY2020 · TW · contact PI
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$117,467
D43 · FY2020 · TW
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$107,210
D43 · FY2020 · TW
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$61,776
D43 · FY2020 · TW
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$61,776
D43 · FY2020 · TW
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$6,000
D43 · FY2020 · TW
Primary prevention of stroke in children with SCD in Sub-Saharan Africa II$1,022,211
R01 · FY2019 · NS
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$993,995
D43 · FY2019 · TW
Optimal Management of HIV Infected Adults at Risk for Kidney Disease in Nigeria$606,799
U01 · FY2019 · DK
Optimal Management of HIV Infected Adults at Risk for Kidney Disease in Nigeria$160,000
U01 · FY2019 · DK
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$100,124
D43 · FY2019 · TW
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$94,945
D43 · FY2019 · TW
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$87,000
D43 · FY2019 · TW
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$76,032
D43 · FY2019 · TW
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$56,160
D43 · FY2019 · TW
Primary prevention of stroke in children with SCD in Sub-Saharan Africa II$1,018,471
R01 · FY2018 · NS
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$1,008,089
D43 · FY2018 · TW
Optimal Management of HIV Infected Adults at Risk for Kidney Disease in Nigeria$629,406
U01 · FY2018 · DK
Bridging the Childhood Epilepsy Treatment Gap in Northern Nigeria (BRIDGE)$179,183
R21 · FY2018 · TW
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$88,135
D43 · FY2018 · TW
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$75,636
D43 · FY2018 · TW
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$59,616
D43 · FY2018 · TW
Primary prevention of stroke in children with SCD in Sub-Saharan Africa II$1,104,445
R01 · FY2017 · NS
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$900,000
D43 · FY2017 · TW
Optimal Management of HIV Infected Adults at Risk for Kidney Disease in Nigeria$647,377
U01 · FY2017 · DK
Bridging the Childhood Epilepsy Treatment Gap in Northern Nigeria (BRIDGE)$193,570
R21 · FY2017 · TW
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)$160,604
D43 · FY2017 · TW
Primary prevention of stroke in children with SCD in Sub-Saharan Africa II$1,150,318
R01 · FY2016 · NS
Primary prevention of stroke in children with SCD in Sub-Saharan Africa II$1,057,951
R01 · FY2015 · NS
Optimizing integrated PMTCT services in rural North-Central Nigeria$440,106
R01 · FY2013 · HD · contact PI
Primary Prevention of Strokes in Nigerian Children with Sickle Cell Disease$134,855
R21 · FY2013 · NS
Optimizing integrated PMTCT services in rural North-Central Nigeria$454,966
R01 · FY2012 · HD · contact PI
Primary Prevention of Strokes in Nigerian Children with Sickle Cell Disease$146,744
R21 · FY2012 · NS